The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis <i>in vivo</i> and reduces skin cancer cell migration <i>in vitro</i>

Belamy B. Cheung(Children's Cancer Institute Australia), Glenn M. Marshall(Children's Cancer Institute Australia)
The Journal of Pathology
August 18, 2011
10.1002/path.2986
Cited by 39

Related Papers

TRIM16 Acts as an E3 Ubiquitin Ligase and Can Heterodimerize with Other TRIM Family Members
|PLoS ONE|2012|115
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
|Nature Communications|2021|87
TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells
|Oncogene|2010|70
High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients
|Cancer Letters|2016|64
TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells
|APOPTOSIS|2013|29